Assuring availability of opioid analgesics for palliative care : report on a WHO workshop, Budapest, Hungary 25-27 February 2002
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Copenhagen : WHO Regional Office for Europe
Abstract
Description
EUR/02/5037079
143p.
Regulatory problems in making opioid analgesics available and a series of policy and professional barriers often prevent proper treatment for people who suffer from severe pain. Over 40 experts from Bulgaria, Croatia, Hungary, Lithuania, Poland and Romania, along with experts from WHO and other organizations, attended the Workshop to evaluate national policies for opioid control and to develop action plans to improve the availability of these drugs for palliative care in their countries. The participants discussed the changes that might need to be made in laws and regulations or drug distribution to achieve this goal. They recognized the need to balance the regulatory requirements for control with the need to make opioids accessible for appropriate pain relief. The participants urged governments to ensure the accessibility of opioids for their population while complying with all international regulatory obligations
143p.
Regulatory problems in making opioid analgesics available and a series of policy and professional barriers often prevent proper treatment for people who suffer from severe pain. Over 40 experts from Bulgaria, Croatia, Hungary, Lithuania, Poland and Romania, along with experts from WHO and other organizations, attended the Workshop to evaluate national policies for opioid control and to develop action plans to improve the availability of these drugs for palliative care in their countries. The participants discussed the changes that might need to be made in laws and regulations or drug distribution to achieve this goal. They recognized the need to balance the regulatory requirements for control with the need to make opioids accessible for appropriate pain relief. The participants urged governments to ensure the accessibility of opioids for their population while complying with all international regulatory obligations